Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 2013

View Archived Issues

Preliminary results of phase I/II trial of novel gene therapy for Wiskott-Aldrich syndrome

New durable submucosal gel to aid endoscopic gastric lesion removal

FXR agonist shows potential for the treatment of hypertension and insulin resistance

CR-4056 reduces experimental postoperative pain

MEDI-551 shows efficacy in patients with CLL

First patients treated in Bioheart's ANGEL study

Exelixis commences pivotal phase III METEOR trial

Roswell Park Cancer Institute and Jasco Pharmaceuticals enter collaboration

European CHMP recommends approval of Teva's Lonquex

Algeta launches anticancer drug Xofigo in the U.S.

Preclinical and phase I results for VTX-2337 in ovarian cancer

Qiagen expands its pipeline of personalized healthcare companion diagnostics

AstraZeneca initiates large studies of biomarker role in NSCLC

AstraZeneca receives MJFF grant to study treatment for LID

FDA grants fast track designation to SGX-942

Merck Serono to collaborate with BeiGene on BeiGene-283

NeuroDiscovery changes name to OncoSil Medical Ltd.

Isis Pharmaceuticals earns milestone payment from AstraZeneca for ISIS-ARRx

Researchers at Actelion disclose new NPS receptor antagonists

Lucentis receives positive CHMP opinion in myopic choroidal neovascularization

Astellas Pharma presents novel RSK inhibitors

New Chk1 inhibitors disclosed by Sentinel Oncology

Bavarian Nordic's smallpox vaccine receives positive opinion from CHMP

Intervet International prepares new DGAT1 inhibitors

Novel oral agent for bowel cleansing launched in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...